• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳性积液细胞学检查作为恶性肿瘤的初始表现。

Positive effusion cytology as the initial presentation of malignancy.

作者信息

Monte S A, Ehya H, Lang W R

出版信息

Acta Cytol. 1987 Jul-Aug;31(4):448-52.

PMID:3604540
Abstract

During a period of four years (1981 to 1984), 641 ascitic, 860 pleural and 47 pericardial fluid specimens were examined cytologically. Of these, 154 ascitic samples, 174 pleural specimens and 10 pericardial effusions, obtained, respectively, from 108, 133 and 7 patients, were found to contain malignant cells. In 7 patients, ascites, and in 18 cases, pleural effusions were the first indication of cancer. None of the positive pericardial fluids was the initial presentation of malignancy. The cytologic findings and follow-up data on these 25 patients are the subject of this study. The most common type of neoplasm in these effusions was adenocarcinoma (86% of the ascitic and 78% of the pleural fluids). Most of the malignant neoplasms in ascitic fluids were derived from ovarian tumors (5 of 7) while those in pleural effusions came mainly from lung tumors (12 of 18). Mammary carcinoma, which was the most common malignant tumor found in cases of pleural effusions, did not present initially with an effusion in any of our cases. The cytologic diagnosis was confirmed in all cases by either biopsy or strong clinical evidence. The prognosis in patients who initially presented with an effusion was poor. All of the patients with an adequate follow-up died within 29 months in cases of ascites and within 19 months in cases of pleural effusions.

摘要

在四年期间(1981年至1984年),对641份腹水、860份胸水和47份心包积液标本进行了细胞学检查。其中,分别从108例、133例和7例患者获得的154份腹水样本、174份胸水标本和10份心包积液中发现含有恶性细胞。7例患者的腹水和18例患者的胸水是癌症的首发表现。所有阳性心包积液均不是恶性肿瘤的初始表现。本研究的主题是这25例患者的细胞学检查结果和随访数据。这些积液中最常见的肿瘤类型是腺癌(腹水的86%和胸水的78%)。腹水中的大多数恶性肿瘤起源于卵巢肿瘤(7例中的5例),而胸水中的恶性肿瘤主要来自肺部肿瘤(18例中的12例)。乳腺癌是胸水中最常见的恶性肿瘤,但在我们所有病例中均未以积液作为初始表现。所有病例的细胞学诊断均通过活检或有力的临床证据得到证实。以积液作为首发表现的患者预后较差。所有进行了充分随访的患者,腹水患者在29个月内死亡,胸水患者在19个月内死亡。

相似文献

1
Positive effusion cytology as the initial presentation of malignancy.阳性积液细胞学检查作为恶性肿瘤的初始表现。
Acta Cytol. 1987 Jul-Aug;31(4):448-52.
2
The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.恶性肿瘤诊断与积液形成之间的间隔,涉及细胞学诊断的作用。
Acta Cytol. 1988 Mar-Apr;32(2):183-7.
3
The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.胸膜和腹腔积液中恶性肿瘤的细胞学诊断
Acta Cytol. 1987 Mar-Apr;31(2):85-97.
4
Cytology of fluids from pleural, peritoneal and pericardial cavities in children. A comprehensive survey.儿童胸腔、腹腔和心包腔积液的细胞学检查。一项综合调查。
Acta Cytol. 1994 Mar-Apr;38(2):209-17.
5
Serous effusions in malignant lymphomas: a review.恶性淋巴瘤中的浆液性积液:综述
Diagn Cytopathol. 2006 May;34(5):335-47. doi: 10.1002/dc.20432.
6
Survival of patients with malignancy-associated effusions.恶性肿瘤相关性胸腔积液患者的生存情况
Acta Cytol. 1989 Nov-Dec;33(6):911-6.
7
Cytological diagnosis of serous effusions in a cancer hospital in Brazil.巴西一家癌症医院中浆液性积液的细胞学诊断
Pathologica. 1996 Apr;88(2):128-31.
8
Significance of pericellular lacunae in cell blocks of effusions.积液细胞块中细胞周围腔隙的意义。
Acta Cytol. 1992 May-Jun;36(3):333-7.
9
The diagnostic yield of pleural fluid cytology in malignant pleural effusions.恶性胸腔积液中胸腔积液细胞学检查的诊断阳性率。
Singapore Med J. 2000 Jan;41(1):19-23.
10
Malignant effusions: from diagnosis to biology.恶性积液:从诊断到生物学
Diagn Cytopathol. 2004 Oct;31(4):246-54. doi: 10.1002/dc.20133.

引用本文的文献

1
Cytologic Histotyping of Gynecologic Malignancies in Peritoneal Fluids Is Reliable When Compared to Its Corresponding Surgical Specimen.与相应手术标本相比,腹腔积液中妇科恶性肿瘤的细胞组织学分型是可靠的。
Diagn Cytopathol. 2025 May;53(5):215-226. doi: 10.1002/dc.25449. Epub 2025 Feb 16.
2
Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".辅助技术在浆液性液体细胞学报告中的作用——“重新定义类别,优化诊断”
J Cytol. 2024 Apr-Jun;41(2):96-104. doi: 10.4103/joc.joc_114_23. Epub 2024 Apr 24.
3
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning.
基于细胞学的深度学习预测不明原发灶癌症的肿瘤起源。
Nat Med. 2024 May;30(5):1309-1319. doi: 10.1038/s41591-024-02915-w. Epub 2024 Apr 16.
4
The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.国际浆液性液体细胞病理学报告系统:关于其在积液细胞学中恶性风险评估及意义的机构经验
J Cytol. 2023 Oct-Dec;40(4):159-164. doi: 10.4103/joc.joc_111_22. Epub 2023 Oct 16.
5
Insights into ovarian cancer: chemo-diversity, dose depended toxicities and survival responses.卵巢癌洞察:化疗多样性、剂量依赖性毒性和生存反应。
Med Oncol. 2023 Mar 4;40(4):111. doi: 10.1007/s12032-023-01976-0.
6
Bilateral Pleural Effusion Revealing a Rare Breast Tumor: A Case Report.双侧胸腔积液揭示罕见乳腺肿瘤:一例报告
Cureus. 2022 Dec 8;14(12):e32312. doi: 10.7759/cureus.32312. eCollection 2022 Dec.
7
Metastatic Carcinoma in Effusions.积液中的转移性癌
Cytojournal. 2022 Jan 31;19:4. doi: 10.25259/CMAS_02_09_2021. eCollection 2022.
8
Serous cavity metastasis: Evaluation of unknown primary.浆膜腔转移:原发灶不明的评估。
Cytojournal. 2022 Mar 19;19:16. doi: 10.25259/CMAS_02_11_2021. eCollection 2022.
9
Clinicopathological Study of 117 Body Fluids: Comparison of Conventional Smear and Cell Block Technique.117份体液的临床病理研究:传统涂片与细胞块技术的比较
Curr Health Sci J. 2020 Oct-Dec;46(4):336-343. doi: 10.12865/CHSJ.46.04.03. Epub 2020 Dec 31.
10
Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.恶性胸腔积液伴发或异时性恶性胸腔积液的预后。
Lung. 2017 Dec;195(6):775-779. doi: 10.1007/s00408-017-0050-1. Epub 2017 Sep 12.